Ignite Creation Date:
2025-12-24 @ 6:55 PM
Ignite Modification Date:
2026-01-01 @ 9:28 AM
Study NCT ID:
NCT05671757
Status:
RECRUITING
Last Update Posted:
2025-07-23
First Post:
2022-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Daratumumab in Primary Antiphospholipid Syndrome
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-24
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-20
First Submit QC Date:
None
Study First Post Date:
2023-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-18
Last Update Post Date:
2025-07-23
Last Update Post Date Type:
ACTUAL